The developing fetus is more sensitive to 2,3,7,8-tetrachloriodibenzo-p-dioxin (TCDD) toxicity than adults with fetal concentration as low as 40 ng kg, while highly exposed humans exceed this concentration by 2-175 times. There is uncertainty in predicting the risk posed by TCDD to human development, because adverse developmental effects observed in laboratory species differ and because the mechanism(s) by which TCDD causes developmental toxicity have not been elucidated. TCDD binds the aryl hydrocarbon receptor (AhR) and dimerizes with the AhR nuclear translocator (ARNT). ARNT also can dimerize with hypoxia-inducible factor 1a and mediate responses to hypoxia, including angiogenesis induced by vascular endothelial growth factor (VEGF). TCDD may cause developmental toxicity by sequestering ARNT and inhibiting hypoxia-induced angiogenesis, in a tissue specific manner. If TCDD inhibits hypoxia induced angiogenesis embryonic development will be at risk, because localized hypoxia stimulates normal tissue angiogenesis in the developing embryo. Using the chick embryo as a model, we will test the hypothesis that TCDD inhibits coronary angiogenesis by inhibiting hypoxia-induced VEGF expression. In the chick embryo, TCDD reduces cardiac VEGF mRNA, prevents ventricular wall thickening, and induces dilated cardiomyopathy, all consistent with and inhibition of coronary angiogenesis.
The aims of this research are to elucidate 1.) The timing and location of hypoxia-induced VEGF expression in the embryo heart, identifying the window of development when the embryo heart is most susceptible to TCDD, 2.) The time-course and dose response for TCDD inhibition of cardiac VEGF mRNA, and 3.) The cellular and morphological consequences of reduced cardiac VEGF expression, including flk-1 receptor expression, coronary angiogenesis, and ventricle wall proliferation. The research will help to elucidate a fundamental mechanism underlying TCDD-induced developmental toxicity, which can then be extrapolated to mammalian and human development.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES009804-03
Application #
6518142
Study Section
Alcohol and Toxicology Subcommittee 4 (ALTX)
Program Officer
Mastin, Patrick
Project Start
2000-04-01
Project End
2004-03-31
Budget Start
2002-04-01
Budget End
2004-03-31
Support Year
3
Fiscal Year
2002
Total Cost
$174,550
Indirect Cost
Name
University of New Mexico
Department
Type
Schools of Pharmacy
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Ivnitski-Steele, Irena D; Friggens, Megan; Chavez, Miquella et al. (2005) 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res A Clin Mol Teratol 73:440-6
Johnson, Charles D; Balagurunathan, Yoganand; Tadesse, Mahlet G et al. (2004) Unraveling gene-gene interactions regulated by ligands of the aryl hydrocarbon receptor. Environ Health Perspect 112:403-12
Ivnitski-Steele, Irena D; Sanchez, Andrea; Walker, Mary K (2004) 2,3,7,8-tetrachlorodibenzo-p-dioxin reduces myocardial hypoxia and vascular endothelial growth factor expression during chick embryo development. Birth Defects Res A Clin Mol Teratol 70:51-8
Ivnitski-Steele, Irena D; Walker, Mary K (2003) Vascular endothelial growth factor rescues 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibition of coronary vasculogenesis. Birth Defects Res A Clin Mol Teratol 67:496-503
Heid, S E; Walker, M K; Swanson, H I (2001) Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol Sci 61:187-96
Catron, T; Mendiola, M A; Smith, S M et al. (2001) Hypoxia regulates avian cardiac Arnt and HIF-1alpha mRNA expression. Biochem Biophys Res Commun 282:602-7
Walker, M K; Heid, S E; Smith, S M et al. (2000) Molecular characterization and developmental expression of the aryl hydrocarbon receptor from the chick embryo. Comp Biochem Physiol C Toxicol Pharmacol 126:305-19
Walker, M K; Catron, T F (2000) Characterization of cardiotoxicity induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol Appl Pharmacol 167:210-21